SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZATELLI, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.678
AS - Asia 10.851
EU - Europa 6.930
SA - Sud America 1.925
AF - Africa 189
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 41.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.233
SG - Singapore 4.653
CN - Cina 3.129
DE - Germania 1.865
BR - Brasile 1.633
UA - Ucraina 1.141
IT - Italia 1.139
HK - Hong Kong 1.123
GB - Regno Unito 680
TR - Turchia 667
VN - Vietnam 561
FI - Finlandia 493
RU - Federazione Russa 458
SE - Svezia 317
PL - Polonia 281
MX - Messico 206
CA - Canada 192
ID - Indonesia 175
AR - Argentina 133
IN - India 133
FR - Francia 131
NL - Olanda 102
ZA - Sudafrica 96
BD - Bangladesh 74
JP - Giappone 73
ES - Italia 66
AT - Austria 60
BE - Belgio 52
IQ - Iraq 51
EC - Ecuador 45
PK - Pakistan 42
LT - Lituania 39
CO - Colombia 24
MA - Marocco 24
VE - Venezuela 24
PY - Paraguay 19
UZ - Uzbekistan 19
KE - Kenya 16
UY - Uruguay 16
CL - Cile 15
IE - Irlanda 14
CZ - Repubblica Ceca 13
DO - Repubblica Dominicana 13
EG - Egitto 13
AU - Australia 12
IL - Israele 12
AE - Emirati Arabi Uniti 11
IR - Iran 11
MY - Malesia 11
NP - Nepal 11
CH - Svizzera 10
EU - Europa 10
SA - Arabia Saudita 10
KR - Corea 9
TN - Tunisia 9
DZ - Algeria 8
JO - Giordania 8
PE - Perù 8
AL - Albania 7
DK - Danimarca 7
JM - Giamaica 7
LV - Lettonia 7
RO - Romania 7
BG - Bulgaria 6
BO - Bolivia 6
OM - Oman 6
PH - Filippine 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
PA - Panama 5
AM - Armenia 4
BH - Bahrain 4
CR - Costa Rica 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
GA - Gabon 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MK - Macedonia 3
RS - Serbia 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BJ - Benin 2
BY - Bielorussia 2
ET - Etiopia 2
LU - Lussemburgo 2
MD - Moldavia 2
ML - Mali 2
Totale 41.569
Salva come PNG Salva come JPEG
Città #
Singapore 2.582
Ashburn 2.531
Woodbridge 2.085
Fairfield 1.883
Chandler 1.487
Jacksonville 1.266
Houston 1.232
Santa Clara 1.119
Hong Kong 1.116
Beijing 1.047
Ann Arbor 842
Seattle 752
Wilmington 708
Cambridge 626
Izmir 409
Los Angeles 384
Nanjing 374
Dallas 370
Munich 362
Princeton 313
New York 303
Warsaw 278
Addison 276
Ferrara 244
Ho Chi Minh City 199
Milan 195
Boardman 185
San Diego 184
Shanghai 177
São Paulo 175
Mexico City 151
Jakarta 138
Hanoi 123
Turku 122
Helsinki 121
Shenyang 119
Nanchang 111
Dearborn 100
London 94
Bremen 92
Hefei 88
Hebei 85
Tianjin 81
Chicago 78
Brooklyn 76
Buffalo 71
Montreal 70
Changsha 69
Denver 69
Moscow 68
Tokyo 66
Washington 61
Boston 57
Chennai 56
Mountain View 56
Atlanta 55
Jiaxing 55
Johannesburg 55
Phoenix 54
Stockholm 54
Falls Church 52
Jinan 52
Toronto 52
Rome 51
Bologna 49
Frankfurt am Main 47
San Francisco 46
Orem 45
Rio de Janeiro 45
The Dalles 45
Brussels 44
Kunming 44
Nuremberg 44
Falkenstein 43
Poplar 42
Redwood City 38
Belo Horizonte 37
Manchester 36
Norwalk 36
Guangzhou 35
Council Bluffs 34
Ankara 30
Tappahannock 29
Amsterdam 28
Campinas 28
Orange 26
Brasília 25
Ningbo 25
Baghdad 24
Porto Alegre 24
San Mateo 23
Auburn Hills 22
Curitiba 22
Vienna 21
Da Nang 20
Des Moines 20
Hải Dương 20
Secaucus 20
Zhengzhou 20
Columbus 19
Totale 27.562
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 394
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 283
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 251
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 237
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 231
Igf-I influences everolimus activity in medullary thyroid carcinoma 223
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 222
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 220
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 219
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 216
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 213
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 212
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 210
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 209
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 206
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 205
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 205
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 200
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 200
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 196
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 195
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 195
Adrenal cavernous hemangioma: a case report 194
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 194
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 191
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 190
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 189
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 185
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 185
Functional characterization of a new deletion in CDKN1B 5'-UTR region 184
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 182
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 182
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 182
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 181
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 180
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 180
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 178
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 175
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 175
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 174
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 174
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 174
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 173
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 172
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 172
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 172
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 171
Growth hormone excess promotes breast cancer chemoresistance 171
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 171
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 171
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors 171
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 170
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 170
Antiproliferative effects of somatostatin analogs in pituitary adenomas 169
Growth hormone induces chemoresistance in breast cancer cells 169
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 168
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 168
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 168
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 167
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 166
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 166
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 166
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 165
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 164
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 164
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 164
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 163
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 163
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 162
miR-15a and miR-16-1 down-regulation in pituitary adenomas 161
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 161
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 161
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 159
Pituitary side effects of old and new drugs. 159
Neck paraganglioma and follicular lymphoma: A case report 159
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 158
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 158
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 158
A new VHL polymorphism in a big family from Ferrara 157
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 157
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 157
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 157
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 155
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation 154
In vitro testing of new somatostatin analogs on pituitary tumor cells 153
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 153
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 153
Cerebral aneurysm and acromegaly: a case report 152
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 152
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 152
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 151
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 151
Levels of p27 sensitize to dual PI3K/mTOR inhibition 150
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family 150
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 150
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 150
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 150
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 149
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 148
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 148
Totale 17.910
Salva come PNG Salva come JPEG
Categoria #
all - tutte 209.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.788
Totale 219.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.989 0 0 0 0 0 341 101 368 98 477 429 175
2021/20222.754 113 256 179 54 118 160 129 151 114 223 266 991
2022/20233.186 321 277 130 435 467 440 168 266 385 26 165 106
2023/20242.076 151 193 103 57 138 315 56 454 58 47 49 455
2024/20257.639 206 165 605 202 929 796 221 311 1.250 974 1.108 872
2025/202611.044 1.974 846 1.797 2.606 3.387 434 0 0 0 0 0 0
Totale 42.164